Skip to contentBelldegrun Arie — LAURIER INTERNATIONAL INC insider: 241 transactions · InsiderLensBelldegrun Arie
- Director at Paramount Acquisition Corp · on record since Jan 31, 2006
- Director at SRKP 4 INC · on record since Apr 13, 2006
- 10% owner at SRKP 4 INC · on record since Apr 13, 2006
- Director at Hana Biosciences Inc · on record since Dec 18, 2006
- 10% owner at LB PHARMACEUTICALS INC · on record since Sep 16, 2025
- Director at LAURIER INTERNATIONAL INC · on record since Jun 13, 2008
- Director at GENENTECH INC · on record since Sep 20, 2021
- Director at SMI PRODUCTS INC · on record since Sep 28, 2009
- Director at Kite Pharma, Inc. · on record since Jun 19, 2014
- Chairman, President and CEO at Kite Pharma, Inc. · on record since Jun 19, 2014
- 10% owner at Kite Pharma, Inc. · on record since Jun 19, 2014
- Director at Allogene Therapeutics, Inc. · on record since Oct 17, 2018
- 10% owner at Allogene Therapeutics, Inc. · on record since Oct 17, 2018
- Director at UroGen Pharma Ltd. · on record since Mar 28, 2019
- Director at KRONOS INC · on record since Oct 16, 2020
- 10% owner at KRONOS INC · on record since Oct 8, 2020
Insider trading activity of Belldegrun Arie
- Transactions on record
- 241
- since Nov 15, 2005
- Open-market buys
- 26
- $21.1M
- Open-market sells
- 2
- $4.9M
- Companies traded
- 10
- last filing Jun 24, 2026
Figures computed from official regulatory filings — methodology.
Companies where Belldegrun Arie has traded
- UroGen Pharma Ltd.18 tx · $1.9M · Jun 24, 2026
- Allogene Therapeutics, Inc.33 tx · $25.9M · Feb 4, 2026
- KRONOS INC20 tx · $6.1M · Jun 20, 2025
- GENENTECH INC8 tx · Jun 14, 2024
- Kite Pharma, Inc.34 tx · $599M · Oct 5, 2017
- LAURIER INTERNATIONAL INC67 tx · $2M · Aug 17, 2016
- SMI PRODUCTS INC3 tx · May 12, 2011
- SRKP 4 INC47 tx · $44.8M · Jul 7, 2009
- Hana Biosciences Inc4 tx · Feb 26, 2009
- Paramount Acquisition Corp
Track record of Belldegrun Arie
Statistical track record
Free- Open-market buys
- 42
- Last buy
- May 16, 2024
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Belldegrun Arie
Co-insiders of Belldegrun Arie
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
7 tx · $31.7K · Jan 31, 2006
CLARK IAN TGENENTECH INC +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 24, 2026 | AwardD | 20,000 | 0.00 USD | — | SEC |
| Feb 4, 2026 | AwardD | 929,913 | 0.00 USD | $0 | SEC |
| Feb 4, 2026 | AwardD | 263,033 | 0.00 USD | $0 | SEC |
| Aug 27, 2025 | AwardD | 20,000 | 0.00 USD | $0 | SEC |
| Jun 20, 2025 | OtherD | -20,600 | 0.00 USD | $0 | SEC |
| Jun 20, 2025 | Other | -2,765,314 | 0.57 USD | $1.6M | SEC |
| Jun 20, 2025 | OtherD | -34,000 | 0.00 USD | $0 | SEC |
| Jun 20, 2025 | OtherD | -34,000 | 0.00 USD | $0 | SEC |
| Jun 20, 2025 | Other | -679,575 | 0.57 USD | $387.4K | SEC |
| Jun 20, 2025 | OtherD | -34,000 | 0.00 USD | $0 | SEC |
| Jan 28, 2025 | AwardD | 1,307,927 | 0.00 USD | $0 | SEC |
| Jan 28, 2025 | Award | 369,957 | 0.00 USD | $0 | SEC |
| Aug 8, 2024 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Jun 26, 2024 | AwardD | 34,000 | 0.00 USD | $0 | SEC |
| Jun 14, 2024 | AwardD | 571,428 | 0.00 USD | $0 | SEC |
| Jun 14, 2024 | AwardD | 432,900 | 0.00 USD | $0 | SEC |
| Jun 14, 2024 | Exercise | 105,263 | — | — | SEC |
| Jun 14, 2024 | ExerciseD | -105,263 | — | — | SEC |
| May 20, 2024 | Award | 344,828 | 2.90 USD | $1M | SEC |
| May 20, 2024 | Buy | 1,724,137 | 2.90 USD | $5M | SEC |
| Jan 31, 2024 | Award | 211,973 | 0.00 USD | $0 | SEC |
| Jan 31, 2024 | AwardD | 749,398 | 0.00 USD | $0 | SEC |
| Sep 8, 2023 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Jun 26, 2023 | AwardD | 34,000 | 0.00 USD | $0 | SEC |
| Jun 21, 2023 | AwardD | 105,263 | 0.00 USD | $0 | SEC |